Lido Advisors
AXDX

Lido Advisors’s Accelerate Diagnostics AXDX Stock Holding History

Lido Advisors’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-163,161
Closed -$114K – 1661
2025
Q1 		$114K Buy
+163,161
New +$186K ﹤0.01% 1436

Other funds holding AXDX

BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
BCWM
Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Lido Advisors's AXDX Position: Q2 2025 in Review

Lido Advisors sold out of Accelerate Diagnostics (AXDX) in Q2 2025, closing a stake of 163,161 shares — an estimated $114K sold.

Lido Advisors first reported a position in AXDX in Q1 2025 and held it in 1 quarter. The position peaked at $114K in Q1 2025. 3 funds tracked by Wall St. Rank hold AXDX as of Q2 2025.

  • Lido Advisors reported no remaining Accelerate Diagnostics position as of Q2 2025 after selling out during the quarter.
  • Lido Advisors sold 163,161 Accelerate Diagnostics shares in Q2 2025, an estimated $114K.
  • Lido Advisors first reported a position in Accelerate Diagnostics in Q1 2025 and held it in 1 quarter.
  • Lido Advisors's Accelerate Diagnostics position peaked at $114K in Q1 2025.
  • 3 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2025.

Based on Lido Advisors's 13F filing for Q2 2025, filed 13 Aug 2025.